Clinical Trial

Tofacitinib in Juvenile Idiopathic Arthritis

Name: Tofacitinib in Juvenile Idiopathic Arthritis — clinical trial record (NCT07211932)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to evaluate, using real-world clinical practice data, the efficacy of tofacitinib in improving the clinical control of juvenile idiopathic arthritis (JIA) after 12 months of treatment.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-10-01.

Trial Details

NCT Number	NCT07211932
Lead Sponsor	Consorci Sanitari de l'Alt Penedès i Garraf
Conditions	Juvenile Idiopathic Arthritis (JIA)
Enrollment	58 participants
Start Date	2025-12
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2025-11-26